# OnCo record agx-148 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/agx-148/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "agx-148" ;
  schema:name "AGX-148"@en ;
  schema:alternateName "CD39+CD103+ double-positive TIL"@en ;
  schema:description "AGX-148 is an experimental cell therapy from AgonOx made from the tumour-recognising immune cells in a patient's own tumour. It is in an early trial in solid tumours."@en ;
  schema:url <https://onco.cc/drugs/agx-148/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.agonox.com/>, <https://clinicaltrials.gov/study/NCT05902520> ;
  onco:status "phase-1" ;
  onco:tag "pipeline" ;
  onco:modality "Autologous tumour-infiltrating lymphocyte therapy" ;
  onco:technologies <https://onco.cc/technologies/til-therapy/> ;
  onco:companies <https://onco.cc/companies/agonox/> .